Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)

The objective is to move devices to their next step in the FDA approval process, with the ultimate goal of generating new, FDA approved device-based treatments for SUDs.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding